Intrathecal Administration Of Mtor Inhibitors For The Therapy Of Neurodegenerative, Neuroinflammatory And Neurooncologic Diseases


Ontology type: sgo:Patent     


Patent Info

DATE

2018-06-13T00:00

AUTHORS

CASSANO, Tommaso , GIOVAGNOLI, Stefano , MAGINI, Alessandro , EMILIANI, Carla

ABSTRACT

The invention relates to the use of inhibitors of the enzyme mTOR kinase (mammalian target of rapamycin) in the treatment of neuro-oncologic diseases, in particular tuberous sclerosis, neurodegenerative diseases, in particular Alzheimer's disease, and neuroinflammatory diseases, in particular multiple sclerosis and primary progressive aphasia, via intrathecal, or preferably intraventricular, administration of said inhibitors. More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2581", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3120", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "CASSANO, Tommaso", 
        "type": "Person"
      }, 
      {
        "name": "GIOVAGNOLI, Stefano", 
        "type": "Person"
      }, 
      {
        "name": "MAGINI, Alessandro", 
        "type": "Person"
      }, 
      {
        "name": "EMILIANI, Carla", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.ejpn.2011.09.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007616631"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00381-010-1222-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026643364", 
          "https://doi.org/10.1007/s00381-010-1222-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00381-010-1222-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026643364", 
          "https://doi.org/10.1007/s00381-010-1222-y"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-06-13T00:00", 
    "description": "

The invention relates to the use of inhibitors of the enzyme mTOR kinase (mammalian target of rapamycin) in the treatment of neuro-oncologic diseases, in particular tuberous sclerosis, neurodegenerative diseases, in particular Alzheimer's disease, and neuroinflammatory diseases, in particular multiple sclerosis and primary progressive aphasia, via intrathecal, or preferably intraventricular, administration of said inhibitors.

", "id": "sg:patent.EP-2846770-B1", "keywords": [ "intrathecal administration", "therapy", "disease", "invention", "inhibitor", "enzyme", "mammalian target", "Sirolimus", "Tuberous Sclerosis", "neurodegenerative disease", "Alzheimer's", "neuroinflammatory disease", "multiple sclerosis", "Primary progressive aphasia", "Organization and Administration" ], "name": "INTRATHECAL ADMINISTRATION OF MTOR INHIBITORS FOR THE THERAPY OF NEURODEGENERATIVE, NEUROINFLAMMATORY AND NEUROONCOLOGIC DISEASES", "sameAs": [ "https://app.dimensions.ai/details/patent/EP-2846770-B1" ], "sdDataset": "patents", "sdDatePublished": "2019-04-18T10:22", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-uberresearch-data-patents-target-20190320-rc/data/sn-export/402f166718b70575fb5d4ffe01f064d1/0000100128-0000352499/json_export_01767.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.EP-2846770-B1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.EP-2846770-B1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.EP-2846770-B1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.EP-2846770-B1'


 

This table displays all metadata directly associated to this object as RDF triples.

57 TRIPLES      14 PREDICATES      31 URIs      23 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.EP-2846770-B1 schema:about anzsrc-for:2581
2 anzsrc-for:3120
3 schema:author N472c27365c0448f0a2f242870081e23b
4 schema:citation sg:pub.10.1007/s00381-010-1222-y
5 https://doi.org/10.1016/j.ejpn.2011.09.006
6 schema:datePublished 2018-06-13T00:00
7 schema:description <p>The invention relates to the use of inhibitors of the enzyme mTOR kinase (mammalian target of rapamycin) in the treatment of neuro-oncologic diseases, in particular tuberous sclerosis, neurodegenerative diseases, in particular Alzheimer's disease, and neuroinflammatory diseases, in particular multiple sclerosis and primary progressive aphasia, via intrathecal, or preferably intraventricular, administration of said inhibitors.</p>
8 schema:keywords Alzheimer's
9 Organization and Administration
10 Primary progressive aphasia
11 Sirolimus
12 Tuberous Sclerosis
13 disease
14 enzyme
15 inhibitor
16 intrathecal administration
17 invention
18 mammalian target
19 multiple sclerosis
20 neurodegenerative disease
21 neuroinflammatory disease
22 therapy
23 schema:name INTRATHECAL ADMINISTRATION OF MTOR INHIBITORS FOR THE THERAPY OF NEURODEGENERATIVE, NEUROINFLAMMATORY AND NEUROONCOLOGIC DISEASES
24 schema:sameAs https://app.dimensions.ai/details/patent/EP-2846770-B1
25 schema:sdDatePublished 2019-04-18T10:22
26 schema:sdLicense https://scigraph.springernature.com/explorer/license/
27 schema:sdPublisher N0ff8ca494e074e7684137dd0395ef3af
28 sgo:license sg:explorer/license/
29 sgo:sdDataset patents
30 rdf:type sgo:Patent
31 N0ff8ca494e074e7684137dd0395ef3af schema:name Springer Nature - SN SciGraph project
32 rdf:type schema:Organization
33 N387ab6f68b9a4bca97e4c1e17c67e530 rdf:first N7e0d7801da594495ba09caae6acc9d94
34 rdf:rest Nfe0cff4e4991480aa478cde8ecf923aa
35 N472c27365c0448f0a2f242870081e23b rdf:first Nf72ff70315cb44f99d8855171677514a
36 rdf:rest N6d609d5f9ad4443b9e1f9f22e8736394
37 N6d609d5f9ad4443b9e1f9f22e8736394 rdf:first Nd9c8e370fd3d47d9950e0a18ca86b717
38 rdf:rest N387ab6f68b9a4bca97e4c1e17c67e530
39 N7e0d7801da594495ba09caae6acc9d94 schema:name MAGINI, Alessandro
40 rdf:type schema:Person
41 Nc9de29c66d00480cb7e83fb39eb66c27 schema:name EMILIANI, Carla
42 rdf:type schema:Person
43 Nd9c8e370fd3d47d9950e0a18ca86b717 schema:name GIOVAGNOLI, Stefano
44 rdf:type schema:Person
45 Nf72ff70315cb44f99d8855171677514a schema:name CASSANO, Tommaso
46 rdf:type schema:Person
47 Nfe0cff4e4991480aa478cde8ecf923aa rdf:first Nc9de29c66d00480cb7e83fb39eb66c27
48 rdf:rest rdf:nil
49 anzsrc-for:2581 schema:inDefinedTermSet anzsrc-for:
50 rdf:type schema:DefinedTerm
51 anzsrc-for:3120 schema:inDefinedTermSet anzsrc-for:
52 rdf:type schema:DefinedTerm
53 sg:pub.10.1007/s00381-010-1222-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1026643364
54 https://doi.org/10.1007/s00381-010-1222-y
55 rdf:type schema:CreativeWork
56 https://doi.org/10.1016/j.ejpn.2011.09.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007616631
57 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...